These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1837790)
1. Effect of dopamine, L-dopa, carbidopa and L-dopa/carbidopa on arthus and delayed hypersensitivity skin reactions in the rat. Horvat J; Stojić Z; Janković BD Int J Neurosci; 1991 Jul; 59(1-3):199-203. PubMed ID: 1837790 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells. Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119 [TBL] [Abstract][Full Text] [Related]
3. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry. Hefti F; Melamed E Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794 [TBL] [Abstract][Full Text] [Related]
4. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease. Hossain MA; Weiner N J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772 [TBL] [Abstract][Full Text] [Related]
5. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum. Kaakkola S; Wurtman RJ J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137 [TBL] [Abstract][Full Text] [Related]
6. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography. Blunt SB; Jenner P; Marsden CD Neuroscience; 1991; 43(1):95-110. PubMed ID: 1681462 [TBL] [Abstract][Full Text] [Related]
7. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
8. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Männistö PT; Tuomainen P Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471 [TBL] [Abstract][Full Text] [Related]
9. Effect of hydrocortisone, cyclophosphamide, azathioprine and methotrexate on cutaneous delayed and arthus hypersensitivity in the rat. Mansour A; Nelson DS Int Arch Allergy Appl Immunol; 1979; 60(1):50-9. PubMed ID: 156699 [TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. Perry TL; Yong VW; Ito M; Foulks JG; Wall RA; Godin DV; Clavier RM J Neurochem; 1984 Oct; 43(4):990-3. PubMed ID: 6147392 [TBL] [Abstract][Full Text] [Related]
11. Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats. Badawi GA; Abd El Fattah MA; Zaki HF; El Sayed MI Neurotox Res; 2019 Apr; 35(3):635-653. PubMed ID: 30673988 [TBL] [Abstract][Full Text] [Related]
12. L-dopa and streptozotocin-induced diabetic nephropathy in rats. Barthelmebs M; Vailly B; Velly J; Grima M; Imbs JL Am J Hypertens; 1990 Jun; 3(6 Pt 2):72S-74S. PubMed ID: 2143390 [TBL] [Abstract][Full Text] [Related]
13. D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats. Karoum F; Freed WJ; Chuang LW; Cannon-Spoor E; Wyatt RJ; Costa E Brain Res; 1988 Feb; 440(1):190-4. PubMed ID: 3129126 [TBL] [Abstract][Full Text] [Related]
14. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release. Maayan ML; Sellitto RV; Volpert EM Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890 [TBL] [Abstract][Full Text] [Related]
15. DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons. Atlas D CNS Neurosci Ther; 2016 Jun; 22(6):461-7. PubMed ID: 26861609 [TBL] [Abstract][Full Text] [Related]
16. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats. Rose S; Jenner P; Marsden CD Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899 [TBL] [Abstract][Full Text] [Related]
17. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107 [TBL] [Abstract][Full Text] [Related]
18. Dopamine and L-dopa potentiation of pressor responses to norepinephrine in isolated perfused rat kidneys. Lam BK; Stier CT; Wynn NC; Itskovitz HD J Cardiovasc Pharmacol; 1986; 8(3):554-8. PubMed ID: 2425172 [TBL] [Abstract][Full Text] [Related]
19. 3-O-methyl-DOPA is not involved in the development of behavioral supersensitivity after repeated L-dopa administration in 6-OHDA lesioned rats. Bräutigam K; Sohr R; Morgenstern R Behav Brain Res; 1994 Jul; 63(1):41-5. PubMed ID: 7945976 [TBL] [Abstract][Full Text] [Related]
20. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism. Melamed E; Hefti F; Bitton V; Globus M Neurology; 1984 Dec; 34(12):1566-70. PubMed ID: 6504328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]